Measles Virus Strain Diversity, Nigeria and Democratic Republic of the Congo
Jacques R. Kremer, Edith Nkwembe, Akeeb O. Bola Oyefolu, Sheilagh B. Smit, Elisabeth Pukuta, Sunday A. Omilabu, Festus D. Adu, Jean-Jacques Muyembe Tamfum, and Claude P. Muller
Author affiliations: Centre de Recherche Publique–Santé/Laboratoire National de Santé, Luxembourg, Luxembourg (J.R. Kremer, C.P. Muller); Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo (E. Nkwembe, E. Pukuta, J.-J.M. Tamfum); Lagos State University, Lagos, Nigeria (A.O.B. Oyefolu); National Institute for Communicable Diseases, Johannesburg, South Africa (S.B. Smit); University of Lagos, Lagos (S.A. Omilabu); University of Ibadan, Ibadan, Nigeria (F.D. Adu)
Figure 2. Epidemic curve of measles epidemic in Kinshasa, Democratic Republic of the Congo, 2005. Numbers of reported measles cases per week are shown by epidemiologic week, and measles incidence per week in the 35 health districts of Kinshasa is illustrated by gray shading. The periods during which the main genotype B2 variants (B2KIN-A, -B, and -C) were identified in Kinshasa are indicated above the epidemic curve.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.